Endocan, a 50 kDa soluble proteoglycan, also called endothelial cell-specific molecule-1 (ESM-1), is involved in many major cellular activities and has been reported to be overexpressed in inflammatory conditions. This study aims to determine ESM-1 levels in gingival crevicular fluid (GCF) samples from individuals with periodontitis to determine the correlation between the levels of lymphocyte-function-associated antigen-1 (LFA-1), intercellular adhesion molecule-1 (ICAM-1), and clinical findings of periodontitis. This study enrolled 27 individuals diagnosed with Stage III-Grade C generalized periodontitis and 16 individuals as healthy controls. Bleeding on probing (BOP), probing pocket depth (PPD), and clinical attachment loss (CAL) were calculated. Enzyme-linked immunosorbent assay (ELISA) test was used for detecting the levels of ESM-1, ICAM-1, and LFA-1 in GCF samples. PPD, BOP, CAL, and GCF volumes were significantly increased in patients with periodontitis in comparison to the control group (p < 0.001). The total amount of ESM-1, ICAM-1, and LFA-1 levels in GCF were increased in the periodontitis group (p < 0.001). ESM-1 level correlated with PPD, BOP, and CAL (p < 0.05). ICAM-1 level correlated with BOP and CAL (p < 0.05). LFA-1 level correlated with PPD and CAL (p < 0.05). Our data indicate that ESM-1, ICAM-1, and LFA-1 levels are increased in GCF of patients with periodontitis. These molecules could be associated with the pathogenesis and progression of periodontal disease.
The aim of this study was to assess gingival and periodontal-phenotype by using Standard-Periodontal-Probing (SPP), Colored-Periodontal-Probing (CPP), and Cone-Beam-Computed-Tomography (CBCT) in comparison to gold standard transgingival-probing. Gingival-thickness of the maxillary anterior incisors and canines of 30 healthy individuals (6 teeth of each individual) was evaluated by transgingival-probing, SPP, CPP, and CBCT methods. The relationship between thin and thick phenotype and phenotypic parameters such as age, gender, Keratinized-Tissue-Width (KTW), and Buccal-Bone-Thickness (BBT) was tested with the Chi-square test, and the differences between the measurements were tested with the Mann-Whitney U test. Gingival-thickness, BBT, and related phenotypic parameters were measured from three buccal points (marginal-middle-apical) of each tooth, and Spearman-Rho Correlation Analysis was performed. Pearson chi-square and McNemar tests were used to assess the distribution of categorical data. Sensitivity, specificity and accuracy levels and kappa statistics were calculated for each method. Intra/interobserver agreement was assessed using the intraclass correlation coefficient. The significance level was set at p < 0.05. There was no statistically significant difference for gingival-phenotype according to age and gender (p > 0.05). Higher KTW values were measured in areas with thick gingival-phenotype (p:0.008). The highest agreement in terms of detecting gingival-phenotype was found between transgingival-probing and CBCT (p < 0.01). All methods were found to be more accurate in the determination of thin phenotype (p < 0.01). Marginal gingival-thickness measurements were higher than those of middle and apical measurements (p < 0.01), and middle BBT measurements were higher than those of apical measurements (p < 0.01). Gingival-thickness measured by transgingival-probing and CBCT showed a significant correlation (p < 0.01). KTW was significantly correlated with BBT and marginal gingival-thickness (p < 0.01). Thin or thick phenotype is associated with different apical-coronal points and KTW. The CBCT method was found to be helpful in determining gingival and periodontal-phenotype. Available CBCT images can be used to take precautions and assess prognosis before implant placement and orthodontic treatment. Not applicable.
17 December 2018 in Combinatorial Chemistry & High Throughput Screening
Background: Ischemia-modified albumin (IMA) is a systemic indicator of inflammatory diseases and is suggested as an oxidative stress marker. Objective: To determine the IMA and high-sensitivity C-reactive protein (hsCRP) serum levels for patients with chronic periodontitis (CP) and to evaluate the impact of non-surgical periodontal therapy on serum IMA and hsCRP levels. Methods: Twenty one systemically healthy patients with CP and 15 systemically and periodontally healthy controls (C) were enrolled in the study. Periodontal pocket depth (PPD), bleeding on probing (BOP) and attachment loss (AL) were recorded at the time of diagnosis and 6 weeks after the non-surgical periodontal therapy. Blood samples were obtained before and after treatment from all groups, and serum IMA and hsCRP levels were evaluated by ELISA method. Results: All of the clinical findings were found to be elevated in the CP group in comparison to C group (p<0.05). Levels of IMA and hsCRP were higher in the CP group (p<0.05) and decreased after non-surgical periodontal therapy (p<0.05). Positive correlations were determined between PPD, BOP and hsCRP (p<0.05) as well as between PPD, AL, BOP and IMA levels (p<0.01) before treatment. A significant positive correlation was also observed between hsCRP and IMA (p<0.01) before and after treatment. Conclusion: IMA is a marker indicating systemic inflammation during periodontal disease, and significantly reduced as a result of non-surgical periodontal therapy. Therefore, IMA might be suggested as a useful indicator of periodontal disease.